Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents - Wikidata - wikimedia - TriplyDB

Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents

Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents

http://www.wikidata.org/entity/Q37002849

about

Perspectives on new synthetic curcumin analogs and their potential anticancer properties Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine 5-Hydroxymethylfurfural (HMF) as a building block platform: Biological properties, synthesis and synthetic applications Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells Chemopreventive potential of curcumin in prostate cancer Iron and cancer: more ore to be mined.Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity Curcumin in cell death processes: a challenge for CAM of age-related pathologies.Curcumin: from ancient medicine to current clinical trials.Androgen receptor antagonists and anti-prostate cancer activities of some newly synthesized substituted fused pyrazolo-, triazolo- and thiazolo-pyrimidine derivatives.Multidrug resistance-selective antiproliferative activity of Piper amide alkaloids and synthetic analogues Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs.Curcumin and its analogue induce apoptosis in leukemia cells and have additive effects with bortezomib in cellular and xenograft models Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin.The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects Recent advances in the investigation of curcuminoids.Structures in solid state and solution of dimethoxy curcuminoids: regioselective bromination and chlorination.Synthesis and evaluation of electron-rich curcumin analogues 1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-κB signaling pathway.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.Synthesis and Cytotoxic Evaluation of Monocarbonyl Analogs of Curcumin as Potential Anti-Tumor Agents.Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists Human papilloma virus 16 E6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers.CoMFA, CoMSIA, HQSAR and Molecular Docking Analysis of Ionone-based Chalcone Derivatives as Antiprostate Cancer Activity Nanotechnology-applied curcumin for different diseases therapy.Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives.Synthesis and Evaluation of the Anti-Oxidant Capacity of Curcumin Glucuronides, the Major Curcumin Metabolites Inhibition of human glutathione S-transferases by curcumin and analogues.Mannich Curcuminoids as Potent Anticancer Agents.

P2860

Q26851248-51BCD921-FF60-41CA-B41D-9E05B873266D Q27008916-F4780637-53F4-4AC4-8A5A-72C0D8EDD026 Q29029982-41476597-D9FE-4069-82A7-37C86D2AA0B7 Q30493841-66EE189D-9F2D-4167-9414-0D8A4DE69D70 Q33646014-A6429A9F-AE43-4A74-9794-D121583F97F7 Q33677592-B3DBFC6A-1ADA-45AE-8327-5A70B8869FF3 Q34555833-E0A148A0-B6A9-40D3-A647-ED92A07AC223 Q34580050-9B9F33D8-0027-4741-8F90-ADF29C1BE520 Q34589151-9231E3FD-F26C-4445-ABA3-F340496C819E Q34685906-0B2E0983-273B-42EE-91F9-BCF2A62BB92A Q35197426-FFB0309F-14F9-4BD3-A0AC-A0FF57EF2726 Q35434794-A086F8F2-9CCA-407E-A70D-0433FCDC5D73 Q35667904-CDC4A0C5-F5F9-4AAD-9313-F774E3FB9408 Q35893304-16E23C31-4AE7-4C3F-B110-1300482DCC4D Q35946294-A25EE8D3-20EC-4490-91EE-28DA487D609B Q36035450-93FCAEBB-0D95-4114-A054-E35BD7887B18 Q36117828-D8238FD6-C513-4DD1-B427-2A3D83D43125 Q36328210-9A4E1CCB-3D13-452F-B63C-39C7B520E588 Q36372894-36C4CBF1-FF29-4465-B466-135FD7CC66BC Q36663085-AD0FD946-7716-474D-AE0C-9A94AAD6DE27 Q36957175-D8192093-4135-4A11-AD0F-6196EDCF1393 Q37037997-9B679B8F-7B2E-42C3-A8C7-B3D64C868483 Q37367112-B75A7AFB-3716-43BF-ACCF-23769875F4CF Q37515723-F49A2D63-41B2-408F-BC54-281DBC2BC3EB Q37699332-BD80773E-0F79-48C3-B5D6-95BA20194A3B Q37708511-4054696E-5280-499C-B44C-1169035CF788 Q38203819-CB218FD1-76B0-4762-BD02-D67E697C35CD Q38790667-BDC7DD83-B1B6-4F6B-BD03-385B751F3928 Q38796610-0C426CFA-E81B-491C-9E52-FB0E40575C9E Q38908668-C17ED334-4DD7-487D-9852-3F884A8D0FEA Q39023495-0099CCE7-A077-4A7B-8A53-79FEF0FC869B Q39044440-050F97DB-34C1-47DA-88EE-2D566ECBA4D7 Q39320831-E8E02669-A209-4D25-8ED5-6F6E5BCA5D1A Q39406759-F9DE426B-48BE-44D9-9226-8B0D81B24970 Q40860463-6756A661-8D4B-4E3F-8541-B7E0261F7A1E Q40997969-6B5E9353-276E-466D-8CA8-520246C141C9 Q41973458-93B8EE47-8987-4A35-BF55-C3AE1AFFBC1F Q41980814-5EE5F927-7C44-4AEE-A1D5-982880C5F387 Q46059073-5C332282-F23A-49C5-8C3E-3F3E5E98E81E Q48088000-E0287645-0E13-4592-80E5-F0BC15A78A25

P2860

Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents

http://www.wikidata.org/entity/Q37002849

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antitumor agents. 250. Design ...... al anti-prostate cancer agents

@en

Antitumor agents. 250. Design ...... l anti-prostate cancer agents.

@nl

type

label

Antitumor agents. 250. Design ...... al anti-prostate cancer agents

@en

Antitumor agents. 250. Design ...... l anti-prostate cancer agents.

@nl

prefLabel

Antitumor agents. 250. Design ...... al anti-prostate cancer agents

@en

Antitumor agents. 250. Design ...... l anti-prostate cancer agents.

@nl

P1433

Q37002849-915CDC2F-9BEE-4FCA-9897-379B7D2D2E31

P1476

Q37002849-D7A94689-36F0-4F38-9243-A31C9F04CE37

P2093

Q37002849-3820C1BD-1FB6-40A5-9907-882F75831B26

Q37002849-39CB8F21-ED82-49E3-8E26-79BB8517C9EE

Q37002849-879B69E9-94B2-4C95-9E51-CDECFD3ECC87

Q37002849-9504145C-7AB3-454E-80AB-351E4DB9F219

Q37002849-96F661CF-BD96-41EB-BAE1-F83947AADA9E

Q37002849-DE0835ED-BB76-45B6-A70B-C3C9B6BE0711

Q37002849-FFF3447A-BEEA-49EF-A19F-7F7EE51AE4D4

P2860

Q37002849-140B8085-D941-4699-AAA7-357AFCA775B5

Q37002849-233DF2B1-62A8-42AC-8202-D28A685D359B

Q37002849-361F7550-EB01-4D31-89FB-723BCE0C00F8

Q37002849-37C72F47-EEB8-4B88-BE83-38DE326C0AAE

Q37002849-4465890F-E4C1-4F6C-B35F-A4D8D5013393

Q37002849-48C41E84-D888-44EF-9DFD-3CDA3F7FF349

Q37002849-4D6966DA-6FA9-4510-BA80-FF7A06EAAB26

Q37002849-512D1107-FE75-471A-BA02-BAAE5F19EF31

Q37002849-6C3C7B4C-764A-453A-99AF-5CD79BA9686B

Q37002849-9535A8A4-9676-49A6-9ED5-DEEA77589401

P304

Q37002849-06641236-B021-4D0D-82BE-AE5B39793E42

P31

Q37002849-72669247-84F9-49C3-96AD-6CB118B558FB

P356

Q37002849-492FD618-BF3D-4E8A-A9A5-056EAB60D0C0

P407

Q37002849-E9C3DB3F-F1F4-4456-A587-84326C3DBDB4

P433

Q37002849-B2ED4521-5B93-4845-A8FD-FFF5611D28B0

P478

Q37002849-441237E2-E8B8-445F-8AEE-FE33EFDCA8B3

P50

Q37002849-9AFE726C-6B79-42BF-AE06-ED421E7E5C89

P577

Q37002849-8ABF14CB-59BA-46BA-96F2-714018F2F9F7

P5875

Q37002849-06E3285F-63DF-4024-B954-C1C31CB0F9E3

P698

Q37002849-90F330EE-6DB4-4FF9-85BB-0F171AE7581D

P921

Q37002849-526d1c62-e7c4-47a7-ae7f-7d394aea0861

P932

Q37002849-87C8F55E-69F4-4CDD-BCB4-08B31285090E

P356

P1433

Journal of Medicinal Chemistry

P1476

Antitumor agents. 250. Design ...... al anti-prostate cancer agents

@en

P2093

Charles C-Y Shih

http://www.w3.org/2001/XMLSchema#string

Chin-Chung Wu

http://www.w3.org/2001/XMLSchema#string

Ching-Yuan Su

http://www.w3.org/2001/XMLSchema#string

Kenneth F Bastow

http://www.w3.org/2001/XMLSchema#string

Kuo-Hsiung Lee

http://www.w3.org/2001/XMLSchema#string

Li Lin

http://www.w3.org/2001/XMLSchema#string

Qian Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for antagonism and resistance of bicalutamide in prostate cancer

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.

International trends and patterns of prostate cancer incidence and mortality.

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.

Anticancer potential of curcumin: preclinical and clinical studies.

The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.

Use of cyproterone acetate in prostate cancer.

Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.

Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents.

Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids.

P304

3963-3972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM051043Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Alexander K. Nyarko

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6994118

http://www.w3.org/2001/XMLSchema#string

P698

16789753

http://www.w3.org/2001/XMLSchema#string

P921

P932

2597393

http://www.w3.org/2001/XMLSchema#string